Prosperity Bancshares, Inc. (PB) EPS Estimated At $1.14; 13 Analysts Are Bullish Allscripts Healthcare Solutions, Inc. (MDRX) Last Week

April 20, 2018 - By Maria Brooks

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Logo

Analysts expect Prosperity Bancshares, Inc. (NYSE:PB) to report $1.14 EPS on April, 25 before the open.They anticipate $0.15 EPS change or 15.15% from last quarter’s $0.99 EPS. PB’s profit would be $79.62M giving it 16.13 P/E if the $1.14 EPS is correct. After having $0.99 EPS previously, Prosperity Bancshares, Inc.’s analysts see 15.15% EPS growth. The stock increased 2.15% or $1.55 during the last trading session, reaching $73.57. About 203,908 shares traded. Prosperity Bancshares, Inc. (NYSE:PB) has risen 5.31% since April 20, 2017 and is uptrending. It has underperformed by 6.24% the S&P500.

Among 26 analysts covering Allscripts-Misys Healthcare (NASDAQ:MDRX), 13 have Buy rating, 1 Sell and 12 Hold. Therefore 50% are positive. Allscripts-Misys Healthcare had 68 analyst reports since August 5, 2015 according to SRatingsIntel. The stock has “Buy” rating by Cantor Fitzgerald on Thursday, February 15. The stock has “Buy” rating by Jefferies on Thursday, June 22. The firm has “Neutral” rating given on Friday, December 2 by Dougherty & Company. The company was maintained on Friday, November 3 by Robert W. Baird. The rating was maintained by Jefferies with “Buy” on Friday, October 27. The firm earned “Buy” rating on Friday, October 16 by Jefferies. The firm has “Hold” rating by Piper Jaffray given on Wednesday, August 23. The firm earned “Buy” rating on Friday, September 15 by Robert W. Baird. The firm earned “Outperform” rating on Monday, September 11 by Cowen & Co. As per Monday, January 8, the company rating was maintained by Cantor Fitzgerald. See Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) latest ratings:

05/04/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $18.0000 Maintain
27/03/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $18.0000 Maintain
06/03/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $18.0 Maintain
27/02/2018 Broker: Bank of America Rating: Buy New Target: $17.0
16/02/2018 Broker: Wells Fargo Rating: Buy New Target: $19.0
16/02/2018 Broker: Piper Jaffray Rating: Hold New Target: $15.0 Maintain
16/02/2018 Broker: Canaccord Genuity Rating: Buy New Target: $17.0 Maintain
15/02/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $18.0 Maintain
19/01/2018 Broker: Evercore Rating: Outperform New Target: $17.5 Initiates Coverage On
16/01/2018 Broker: SunTrust Old Rating: Buy New Rating: Hold Downgrade

Among 21 analysts covering Prosperity Bancshares (NYSE:PB), 4 have Buy rating, 5 Sell and 12 Hold. Therefore 19% are positive. Prosperity Bancshares had 59 analyst reports since July 28, 2015 according to SRatingsIntel. As per Friday, April 28, the company rating was downgraded by Wood. The company was maintained on Monday, June 26 by Hovde Group. As per Monday, May 9, the company rating was upgraded by Raymond James. The stock has “Hold” rating by Keefe Bruyette & Woods on Thursday, December 21. SunTrust maintained the shares of PB in report on Wednesday, January 24 with “Buy” rating. The firm has “Underperform” rating by Sterne Agee CRT given on Wednesday, August 26. The rating was maintained by Hovde Group on Tuesday, February 6 with “Sell”. Sterne Agee CRT initiated the stock with “Underperform” rating in Thursday, August 20 report. Wedbush initiated the stock with “Neutral” rating in Friday, October 7 report. As per Tuesday, November 28, the company rating was maintained by SunTrust.

Prosperity Bancshares, Inc. operates as bank holding firm for the Prosperity Bank that provides a range of retail and commercial banking services to small and medium-sized businesses, and consumers. The company has market cap of $5.14 billion. The firm offers various deposit products, including demand, savings, money market, and time accounts. It has a 18.78 P/E ratio. It also provides one to four family residential mortgage loans, commercial mortgage and multifamily residential loans, commercial and industrial loans, agricultural real estate loans, and non-real estate agricultural loans, as well as construction, land development, and other land loans; consumer loans, such as automobile, recreational vehicle, boat, home improvement, personal, and deposit account collateralized loans; and consumer durables and home equity loans, as well as debit and credit cards.

The stock decreased 0.72% or $0.09 during the last trading session, reaching $12.38. About 684,891 shares traded. Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has declined 6.63% since April 20, 2017 and is downtrending. It has underperformed by 18.18% the S&P500.

Since December 14, 2017, it had 0 buys, and 5 selling transactions for $772,395 activity. Poulton Richard J. sold $213,840 worth of stock. Black Paul had sold 15,000 shares worth $215,292. $68,629 worth of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) was sold by Farley Brian.

Allscripts Healthcare Solutions, Inc. provides information technology and services to healthcare organizations in the United States, Canada, and internationally. The company has market cap of $2.20 billion. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. It currently has negative earnings. The companyÂ’s Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services.

Prosperity Bancshares, Inc. (NYSE:PB) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.